CVSA vs LOPE
Covista Inc. and Grand Canyon Education, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CVSA | LOPE |
|---|---|---|
| Revenue | $2.0B | $1.1B |
| Net income | $251.6M | $216.2M |
| Gross margin | 57.3% | · |
| Net margin | 12.9% | 19.5% |
| Return on equity | 17.5% | 28.2% |
| Diluted EPS | $7.04 | $7.71 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $392.7M | $238.6M |
| Equity | $1.4B | $746.9M |
| Net debt / equity | 0.18× | · |
| Current ratio | 1.09× | 3.65× |
| Revenue CAGR 5y | 16.8% | 5.6% |
| Profit CAGR 5y | 29.1% | −3.4% |
CVSA bills 1.8× the revenue of LOPE, and LOPE keeps more of each dollar of revenue as profit (19.5% against 12.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CVSA | LOPE |
|---|---|---|
| FY2025 | $2.0B | $1.1B |
| FY2024 | $1.8B | $1.0B |
| FY2023 | $1.6B | $960.9M |
| FY2022 | $1.5B | $911.3M |
| FY2021 | $1.4B | $896.6M |
| FY2020 | $899.2M | $844.1M |
| FY2019 | $866.4M | $778.6M |
| FY2018 | $1.0B | $845.5M |
| FY2017 | $960.3M | $974.1M |
| FY2016 | $1.2B | $873.3M |
Bottom line
| Fiscal year | CVSA | LOPE |
|---|---|---|
| FY2025 | $251.6M | $216.2M |
| FY2024 | $237.1M | $226.2M |
| FY2023 | $136.8M | $205.0M |
| FY2022 | $93.4M | $184.7M |
| FY2021 | $311.0M | $260.3M |
| FY2020 | $70.0M | $257.2M |
| FY2019 | $-85.3M | $259.2M |
| FY2018 | $95.2M | $229.0M |
| FY2017 | $33.8M | $203.3M |
| FY2016 | $122.3M | $148.5M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$848,015,000 | CVSA |
| FY2024 | +$755,288,000 | CVSA |
| FY2023 | +$623,753,000 | CVSA |
| FY2022 | +$539,520,000 | CVSA |
| FY2021 | +$485,278,000 | CVSA |
| FY2020 | +$55,152,000 | CVSA |
| FY2019 | +$87,784,000 | CVSA |
| FY2018 | +$168,342,000 | CVSA |
| FY2017 | −$13,857,000 | LOPE |
| FY2016 | +$334,565,000 | CVSA |
| FY2015 | +$301,875,000 | CVSA |
| FY2014 | +$1,218,888,000 | CVSA |
| FY2013 | +$1,325,036,000 | CVSA |
| FY2012 | +$1,453,118,000 | CVSA |
| FY2011 | −$76,238,000 | LOPE |
| FY2010 | −$116,582,000 | LOPE |
| FY2009 | +$1,653,279,000 | CVSA |
The higher-revenue side has changed between CVSA and LOPE over this period. The gap has narrowed since the earliest year compared.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −6.7 pp | LOPE |
| FY2024 | −8.6 pp | LOPE |
| FY2023 | −12.7 pp | LOPE |
| FY2022 | −13.8 pp | LOPE |
| FY2021 | −6.5 pp | LOPE |
| FY2020 | −22.7 pp | LOPE |
| FY2019 | −43.2 pp | LOPE |
| FY2018 | −17.7 pp | LOPE |
| FY2017 | −17.3 pp | LOPE |
| FY2016 | −6.8 pp | LOPE |
| FY2015 | −17.1 pp | LOPE |
| FY2014 | −8.8 pp | LOPE |
| FY2013 | −7.8 pp | LOPE |
| FY2012 | −8.0 pp | LOPE |
| FY2011 | +28.8 pp | CVSA |
| FY2010 | +113.8 pp | CVSA |
| FY2009 | +4.2 pp | CVSA |
The higher net margin has changed hands between CVSA and LOPE over this period.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CVSA's net margin has been more volatile than LOPE's over the 17 comparable fiscal years — 28.4 percentage points of standard deviation against 6.9.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CVSA and LOPE over these 17 fiscal years — CVSA led in 3 and LOPE in 14.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CVSA's return on equity has been more volatile than LOPE's over the 17 comparable fiscal years — 8.6 percentage points of standard deviation against 5.6.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CVSA and LOPE over these 17 fiscal years — CVSA led in 1 and LOPE in 16.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.